These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 21455715
1. Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36. Fujita T, Ohue M, Nakajima M, Fujii Y, Miyauchi A, Takagi Y. J Bone Miner Metab; 2011 Sep; 29(5):588-97. PubMed ID: 21455715 [Abstract] [Full Text] [Related]
2. Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial. Hongo M, Miyakoshi N, Kasukawa Y, Ishikawa Y, Shimada Y. J Bone Miner Metab; 2015 Jul; 33(4):432-9. PubMed ID: 25123562 [Abstract] [Full Text] [Related]
6. Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine. Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y. J Int Med Res; 2008 Jul; 36(5):932-41. PubMed ID: 18831886 [Abstract] [Full Text] [Related]
7. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Hadji P, Zanchetta JR, Russo L, Recknor CP, Saag KG, McKiernan FE, Silverman SL, Alam J, Burge RT, Krege JH, Lakshmanan MC, Masica DN, Mitlak BH, Stock JL. Osteoporos Int; 2012 Aug; 23(8):2141-50. PubMed ID: 22159672 [Abstract] [Full Text] [Related]
8. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Ringe JD, Farahmand P, Faber H, Dorst A. Rheumatol Int; 2009 Jan; 29(3):311-5. PubMed ID: 18762944 [Abstract] [Full Text] [Related]
12. The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study. Nakamura T, Osawa M, Itoh M, Yamaguchi H, Iinuma N, Hayakawa Y, Suzuki H, Kamisaki T, Iwayama S, Nishikawa M. J Bone Miner Metab; 2012 Nov; 30(6):715-21. PubMed ID: 22868656 [Abstract] [Full Text] [Related]
15. Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. Roux C, Reid DM, Devogelaer JP, Saag K, Lau CS, Reginster JY, Papanastasiou P, Bucci-Rechtweg C, Su G, Sambrook PN. Osteoporos Int; 2012 Mar; 23(3):1083-90. PubMed ID: 21975559 [Abstract] [Full Text] [Related]
16. [Effect of eel calcitonin derivative (elcatonin) in osteoporosis]. Yoshikawa S, Shiba M, Hoshino T, Igarashi M, Orimo H, Sakuma A, Tsuyama N. Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1717-28. PubMed ID: 6676389 [Abstract] [Full Text] [Related]
17. [Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis]. Ohbayashi H. Nihon Rinsho; 2009 Jan; 67(1):206-12. PubMed ID: 19177774 [Abstract] [Full Text] [Related]
19. Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment. Yoh K, Tanaka K, Ishikawa A, Ishibashi T, Uchino Y, Sato Y, Tobinaga M, Hasegawa N, Kamae S, Yoshizawa M. J Bone Miner Metab; 2005 Jan; 23(2):167-73. PubMed ID: 15750696 [Abstract] [Full Text] [Related]
20. Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial. Endo N, Fujino K, Doi T, Akai M, Hoshino Y, Nakano T, Iwaya T. J Bone Miner Metab; 2017 Jul; 35(4):375-384. PubMed ID: 27465912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]